Rare diseases
Investigational molecules
Locations
Study on Guselkumab and Etanercept for Treating Chronic Plaque Psoriasis in Children Aged 6 to 17 Years
PolandStudy on the Safety and Effectiveness of Pembrolizumab, Lenvatinib, and Quavonlimab for Patients with Advanced Melanoma with Brain Metastases
PolandStudy of Giredestrant Combined with Pertuzumab-Trastuzumab (Phesgo) for Patients with Previously Untreated HER2-Positive, Estrogen Receptor-Positive Locally Advanced or Metastatic Breast Cancer
PolandStudy of CGT9486 and Sunitinib for Patients with Advanced Gastrointestinal Stromal Tumors
PolandStudy of BGB-A425, LBL-007, and Tislelizumab for Patients with Advanced Head and Neck Cancer, Lung Cancer, or Kidney Cancer
PolandStudy Comparing Pembrolizumab and Brentuximab Vedotin for Patients with Relapsed or Refractory Hodgkin Lymphoma
PolandStudy on Ertugliflozin for Children and Teens with Type 2 Diabetes
PolandStudy of Pembrolizumab and Cisplatin for Patients with Stage III-IVA Resectable Head and Neck Cancer
PolandStudy on the Safety and Effectiveness of Pembrolizumab for Patients with Kidney Cancer After Surgery
PolandStudy of Pembrolizumab as Additional Treatment for Patients with High-Risk Locally Advanced Cutaneous Squamous Cell Carcinoma After Surgery and Radiation
PolandStudy on the Safety and Effectiveness of Stereotactic Body Radiotherapy with or without Pembrolizumab for Patients with Unresected Stage I or II Non-Small Cell Lung Cancer
PolandStudy of Pembrolizumab for Patients with Advanced Solid Tumors
PolandTell us about your condition – we search every trial in Europe and connect you with the right site.
